Background Several studies have evaluated the possible association between whole blood
viscoelastic testing (VET) parameters in patients hospitalized for acute Coronavirus disease …

Infection by SARS-CoV-2 is associated with a high risk of thrombosis. The laboratory
documentation of hypercoagulability and impaired fibrinolysis remains a challenge. Our aim …

Abstract Background Coronavirus Disease-19 (COVID-19) is associated with a high rate of
thrombosis, the pathophysiology of which is not well defined. Viscoelastic testing may …

Background Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state;
leading to multiple sequelae. We sought to detect whether thromboelastography (TEG) …

Background SARS-CoV-2 infections are suspected to trigger the coagulation system through
various pathways leading to a high incidence of thromboembolic complications …

Objective To conduct a comprehensive evaluation of coagulation profiles—via traditional
and whole blood thromboelastometry tests—in coronavirus disease 2019 (COVID-19) …

A bstract Coronavirus disease (COVID-19) causes thromboinflammation resulting in a high
incidence of venous thromboembolism (VTE) events, which occur in significant numbers …

Hemostatic unbalance is often observed in patients with coronavirus disease 2019 (COVID-
19), and patients with severe disease are at high risk of developing thromboembolic …

Hypercoagulability and thrombosis remain a challenge to diagnose and treat in severe
COVID-19 infection. The ability of conventional global coagulation tests to accurately reflect …

Background Few studies detail the evolution of COVID-19 associated coagulopathy. We
performed serial thromboelastography (TEG) and laboratory coagulation studies in 40 …